Skip to main content

Table 6 EORTC Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)

From: 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

EORTC QLQ-C30

Baseline (Mean ± SD)

Post-RT (Mean ± SD)

p

Physical Functioning

94.5 ± 10.4

91.6 ± 12.6

0.04

Role Functioning

94.6 ± 9.9

88.8 ± 17.3

0.10

Emotional Functioning

82.2 ± 18.7

79.7 ± 16.6

0.23

Cognitive Functioning

94.9 ± 11.7

92 ± 12.2

0.16

Social Functioning

65.5 ± 40.5

73.2 ± 35.8

0.29

Fatigue

12.1 ± 15.3

17.4 ± 18.3

0.22

Nausea and Vomiting

0.7 ± 3.5

0.7 ± 3.5

0.23

Pain

1.5 ± 4.8

7.2 ± 17.3

0.12

Dyspnoea

10.1 ± 18.6

8.7 ± 20.6

0.72

Insomnia

10.1 ± 15.7

26.1 ± 26.5

0.005

Appetite Loss

1.4 ± 6.9

2.9 ± 9.6

0.33

Constipation

11.6 ± 19.1

17.4 ± 19.8

0.04

Diarrhoea

5.8 ± 12.9

7.2 ± 17.3

0.71

Financial Difficulties

2.9 ± 9.6

2.9 ± 9.6

0.23

Global Health Status

72.5 ± 13.4

72.1 ± 15.8

0.91